Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
|Articles|February 1, 2016
- Pharmaceutical Technology-02-02-2016
- Volume 40
- Issue 2
Sleeve Protector
The Kimtech Pure A4 Sleeve Protector from Kimberly-Clark Professional features barrier protection that shields workers and the garment from hazardous chemicals and biologics.
The Kimtech Pure A4 Sleeve Protector from Kimberly-Clark Professional features barrier protection that shields workers and the garment from hazardous chemicals and biologics. The sleeve provides an additional layer of protection between gloves and lab coat sleeves, reducing the risk of exposure and contamination.
The Kimtech Pure A4 Sleeve Protector is ideal for situations where full coverage isn’t required, but full protection is. The sleeve includes reinforced seams and comes in a range of sizes. It also includes an advance barrier fabric to provide protection against dangerous liquids and thumb loops, for full wrist coverage.
www.Kimtech.com
Articles in this issue
over 10 years ago
Preventing Film Coating Problems by Designover 10 years ago
Going Small to Achieve Commercial-Scale Successover 10 years ago
Innovating for Innovationover 10 years ago
Faster, Cheaper, and Greenerover 10 years ago
Macro Mattersover 10 years ago
Innovative Therapies Require Modern Manufacturing Systemsover 10 years ago
Creating Robust CAPA Systemsover 10 years ago
Measurement Uncertainty without the Mathover 10 years ago
Pharmaceutical Technology, February 2016 Issue (PDF)over 10 years ago
Crossflow Filtration System for Process DevelopmentRelated to this article
PDA/FDA 2026 session maps the GMP audit lifecycle, root cause to CAPA closure, plus a local vs. above-site decision framework and two case studies.
The recently opened NJ spray drying facility doubles capacity for amorphous solid dispersions, addressing solubility limits in roughly 70% of small-molecule pipelines.
Lori Dingledine, QC Director Microbiological Control and GTIC Operations at Genentech, provided input on the regulations surrounding raw material manufacturing and use for ATMPs in a presentation at the 2026 PDA/FDA Joint Regulatory Conference.
FDA opens applications for its Expedited IND Pilot, pairing sponsors with qualified research institutions to test rolling CMC review ahead of first-in-human trials.
2026 approvals, clinical data, and licensing deals are advancing subcutaneous biologics, reducing patient burden, and reshaping biopharma drug strategy.
Karthik Iyer, Eli Lilly, details an AI system linking GMP findings, audits, and deviations for cited, inspection-ready regulatory intelligence.
At the PDA/FDA Joint Regulatory Conference 2026, Helen Motamen, MS
global head, Sanofi Quality Audit, Inspection, Intelligence & Advocacy, at Sanofi, provided advice for creating a strong internal audit program.